mount
epidemiolog
evid
point
associ
metabol
syndrom
nonalcohol
steatohepat
nash
increasingli
recogn
new
epidem
nash
patholog
includ
hepatocellular
balloon
lobular
inflamm
hepatocellular
injuri
apoptosi
hepat
fibrosi
review
relationship
insulin
resist
inflamm
viscer
obes
nash
attempt
shed
light
pathogenesi
major
metabol
diseas
moreov
identifi
loss
carcinoembryon
antigenrel
cell
adhes
molecul
unifi
mechan
link
immunolog
metabol
abnorm
nash
metabol
syndrom
also
known
insulin
resist
lead
caus
mortal
morbid
develop
countri
consist
cluster
metabol
abnorm
includ
viscer
abdomin
obes
dyslipidemia
hypertens
viscer
obes
involv
activ
proinflammatori
signal
pathway
advers
affect
insulin
action
metabol
syndrom
increasingli
character
chronic
subacut
lowgrad
inflammatori
state
moreov
grow
epidemiolog
evid
support
view
metabol
syndrom
also
associ
nonalcohol
fatti
liver
diseas
nafld
progress
form
nonalcohol
steatohepat
nash
nash
patholog
includ
macrosteatosi
well
inflamm
apoptosi
fibrosi
liver
review
articl
relationship
insulin
resist
inflamm
viscer
obes
nash
identifi
loss
carcinoembryon
antigenrel
cell
adhes
molecul
depend
pathway
common
underpin
molecular
mechan
link
insulin
resist
inflammatori
metabol
anomali
character
metabol
diseas
posit
nutrient
suppli
coupl
sedentari
lifestyl
promot
obes
insulin
resist
viscer
adipos
tissu
play
central
role
obes
associ
increas
inflammatori
state
insulin
resist
viscer
obes
may
preced
insulin
resist
revers
could
also
occur
instanc
hyperinsulinemia
caus
impair
hepat
insulin
clearanc
induc
lipid
product
liver
subsequ
redistribut
white
adipos
tissu
store
caus
viscer
obes
convers
ampl
evid
demonstr
viscer
adipos
caus
system
insulin
resist
increas
viscer
adipos
mass
associ
lipolysi
releas
free
fatti
acid
ffa
also
associ
elev
output
adipokin
resistin
modul
togeth
reduc
adiponectin
releas
advers
affect
insulin
action
extraadipocyt
peripher
tissu
caus
system
insulin
resist
semin
studi
hotamisligil
et
al
initi
identifi
hypertroph
viscer
adipos
depot
dynam
tissu
releas
proinflammatori
molecul
obes
human
rodent
origin
model
point
obesityderiv
metabol
stressor
activ
inflamm
adipocyt
result
insulin
resist
autocrin
fashion
sever
group
found
nonadipocyt
cell
main
produc
proinflammatori
factor
adipos
tissu
cell
bone
marrowderiv
macrophag
express
markedli
induc
obes
mount
evid
demonstr
immun
cell
includ
monocyt
macrophag
infiltr
metabol
tissu
white
fat
depot
liver
induc
cytokin
product
releas
obes
aid
process
macrophag
recruit
concomit
rise
secret
chemokin
monocyt
chemoattract
also
known
cc
chemokin
also
secret
fatladen
adipocyt
attract
circul
leukocyt
event
promot
proinflammatori
state
adipos
tissu
eventu
whole
system
import
note
level
chemokin
correl
posit
adipos
tissu
mass
macrophag
undergo
activ
state
depend
respect
whether
proinflammatori
antiinflammatori
signal
elicit
metabol
cue
absenc
obes
fat
accumul
resid
macrophag
immunoregulatori
antiinflammatori
state
produc
secret
low
amount
immun
modul
adipos
increas
excess
energi
suppli
adipos
tissueassoci
macrophag
popul
increas
undergo
shift
proinflammatori
state
releas
proinflammatori
factor
tumor
necrosi
factoralpha
addit
tissueassoci
lymphocyt
switch
small
immunosuppress
regulatori
cell
treg
domin
helper
larg
inflammatori
domin
helper
cell
high
ratio
dentrit
cell
b
cell
mast
cell
neutrophil
infiltr
hypertroph
adipos
tissu
replac
innat
invari
natur
killer
cell
inkt
eosinophil
contribut
adiposityinduc
chang
inflammatori
milieu
mechanist
macrophag
polar
involv
mainli
activ
c
jun
nh
termin
kinas
jnk
inflammatori
signal
pathway
demonstr
protect
effect
select
jnk
delet
macrophag
dietinduc
insulin
resist
tissu
inflammatori
infiltr
inflammatori
role
adipokinesth
hypertroph
white
adipos
tissu
act
activ
endocrin
organ
produc
differ
hormon
chemokin
cytokin
adipokin
proinflammatori
serv
neg
regul
insulin
action
human
rodent
proinflammatori
adipokin
includ
tumor
necrosi
factoralpha
induc
nitric
oxid
synthas
ino
caus
insulin
resist
local
system
multipl
mechan
instanc
blunt
insulin
signal
decreas
tyrosin
phosphoryl
insulin
receptor
substrat
ir
protein
increas
serin
phosphoryl
jnk
kappa
b
kinas
pathway
propag
inflammatori
signal
extraadipocyt
tissu
liver
vascular
system
involv
activ
nfkappa
n
transcript
activ
induct
target
gene
proinflammatori
factor
emphasi
signific
role
inflamm
pathogenesi
insulin
resist
base
find
infus
advers
system
metabol
effect
lead
insulin
resist
rat
deriv
adipos
tissu
obes
normal
physiolog
condit
circul
well
adipos
tissueassoci
level
low
howev
adipos
increas
express
markedli
induc
rodent
human
adipos
tissuederiv
caus
insulin
resist
hyperinsulinemia
metabol
anomali
via
sever
mechan
includ
stimul
lipolysi
white
adipos
tissu
blunt
ir
phosphoryl
insulin
receptor
kinas
respons
insulin
modul
inflammatori
pathway
induc
transcriptionexpress
adipokin
neg
effect
insulin
action
ie
leptin
repress
protect
effect
ie
adiponectin
interleukin
act
either
proor
antiinflammatori
cytokin
depend
cell
tissu
express
role
obes
insulin
resist
remain
subject
debat
despit
report
rise
content
white
adipos
tissu
obes
human
peripher
administr
advers
affect
insulin
signal
part
induc
suppressor
cytokin
signal
express
hepatocyt
select
transgen
overexpress
constitut
activ
hepatocyt
caus
increas
activ
insulin
resist
togeth
elev
hepat
plasma
level
convers
administr
antibodi
amelior
insulin
resist
state
mice
proinflammatori
function
challeng
observ
mice
null
delet
cytokin
develop
obes
system
insulin
resist
hepatosteatosi
hepat
inflamm
cytokin
acut
exert
antiinflammatori
action
skelet
muscl
exercis
surmis
sever
studi
review
recent
exert
differenti
siteand
cellspecif
inflammatori
effect
moreov
chronic
elev
level
condit
elev
adipos
exert
proinflammatori
effect
insulin
action
adipos
tissu
liver
acut
rise
ie
follow
muscl
contract
exercis
appli
antiinflammatori
effect
improv
insulin
sensit
support
benefici
acut
versu
chronic
effect
cytokin
central
administr
decreas
obes
enhanc
energi
expenditur
transgen
overexpress
muscl
lead
insulin
resist
system
hyperinsulinemia
addit
mark
inflammatori
phenotyp
liver
leptin
leptin
kdapeptid
produc
mainli
matur
adipocyt
structur
similar
proinflammatori
helic
cytokin
leptin
induc
inflammatori
respons
upon
bind
long
isoform
receptor
activ
janu
kinas
signal
transduc
activ
transcript
signal
pathway
addit
regul
food
intak
energi
expenditur
leptin
regul
immunolog
respons
diet
instanc
promot
phagocyt
activ
macrophagesmonocyt
activ
phospholipas
productionsecret
proinflammatori
cytokin
leptin
induc
product
human
hepat
stellat
cell
also
induc
releas
proinflammatori
cytokin
suppress
antiinflammatori
cytokin
reciproc
stimul
protein
content
leptin
surfac
express
receptor
defici
leptin
obob
mice
receptor
dbdb
mice
result
obes
insulin
resist
larg
due
hyperphagia
hand
obes
human
rodent
exhibit
chronic
elev
level
leptin
leptinemia
leptin
resist
similarli
develop
hyperinsulinemia
insulin
resist
metabol
condit
review
adiponectin
addit
increas
express
proinflammatori
cytokin
ie
obes
gener
associ
reduc
express
antiinflammatori
factor
eg
adiponectin
adiponectin
secret
mainli
white
adipos
tissu
protect
insulin
action
fat
glucos
metabol
local
also
outsid
adipocyt
name
liver
vascular
tissu
other
mediat
part
activ
ampdepend
protein
kinas
enhanc
fatti
acid
oxid
glucos
uptak
skelet
muscl
decreas
glucos
product
liver
adiponectin
level
low
adipos
tissu
obes
rodent
human
due
suppress
activ
inflammatori
factor
reactiv
oxygen
speci
ro
hypoxia
contrast
agonist
peroxisom
proliferatoractiv
receptor
gamma
induc
express
neither
insulin
sensit
effect
adiponectin
antiinflammatori
effect
human
rodent
disput
mechanist
underpin
adiponectin
function
includ
promot
antiinflammatori
polar
macrophag
phagocyt
activ
apoptot
cell
modul
cell
activ
induc
adiponectin
receptor
express
surfac
cell
antigen
stimul
follow
apoptosismedi
suppress
antigen
specif
cell
expans
modul
inflammatori
function
natur
killer
nk
cell
suppress
toll
like
receptor
tlr
mediat
interferon
gamma
product
without
affect
cytotox
suppress
transcript
proinflammatori
factor
inhibit
signal
inflammatori
pathway
increas
express
adipocyt
induc
express
addit
secret
adipokin
viscer
adipos
tissu
also
releas
ffa
play
major
role
system
insulin
resist
develop
respons
prolong
posit
nutrient
suppli
insulin
resist
white
adipos
tissu
character
increas
lipolysi
ie
fatti
acid
mobil
plasma
major
obes
insulin
resist
individu
elev
level
plasma
ffa
predispos
glucos
intoler
progress
type
diabet
independ
factor
less
sensit
antilipolyt
effect
insulin
subcutan
fat
viscer
fat
suppli
higher
level
ffa
displac
ffa
preferenti
remov
liver
much
lower
extent
muscl
heart
other
accord
portal
hypothesi
mobil
ffa
reach
liver
primarili
via
portal
vein
contribut
insulin
resist
promot
gluconeogenesi
fatti
acid
oxid
lipogenesi
inhibit
insulinmedi
suppress
glycogenolysi
impair
hepat
insulin
clearanc
caus
chronic
hyperinsulinemia
skelet
muscl
level
increas
ffa
uptak
follow
oxid
compet
glucos
oxid
lead
insulin
resist
glucosefatti
acid
cycl
increas
ectop
deposit
fat
liver
skelet
muscl
vasculatur
elev
intracellular
content
ffa
metabolit
activ
signal
pathway
impair
insulin
signal
via
multipl
mechan
includ
activ
protein
kinas
c
pkc
epsilon
lambda
engag
inflammatori
signal
activ
jnk
pathway
lead
increas
express
inflammatori
cytokin
nafld
common
chronic
liver
diseas
worldwid
clinic
diseas
rang
simpl
steatosi
fibros
steatohepat
progress
nonalcohol
steatohepat
nash
nafld
affect
onethird
adult
industri
countri
unit
state
nafld
case
develop
fibros
steatohepat
progress
nash
furthermor
patient
nash
develop
cirrhosi
nash
lead
caus
cirrhosi
hepatocellular
carcinoma
endstag
liver
diseas
thu
diseas
expect
becom
primari
indic
liver
transplant
western
countri
featur
nash
hepat
macrosteatosi
hepatocyt
balloon
inflamm
fibrosi
hepatocyt
damag
apoptosi
pathogenesi
remain
partli
elucid
attend
diagnost
uncertainti
howev
common
underli
twohit
hypothesi
suggest
fat
accumul
liver
first
hit
caus
lipotox
elicit
adapt
intracellular
signal
apoptot
mechan
mediat
lipid
peroxid
oxid
stress
inflamm
loss
hepatocyt
apoptosi
fibrosi
second
hit
nafld
strongli
associ
obes
metabol
syndrom
fact
nafld
regard
hepat
manifest
metabol
syndrom
point
sever
group
mount
epidemiolog
evid
connect
growth
incid
nafld
increas
preval
metabol
syndrom
moreov
wide
accept
treat
metabol
syndrom
improv
liver
function
patient
nafld
metabol
syndrom
compris
constel
find
includ
obes
dyslipidemia
hypertens
insulin
resist
indic
fast
hyperinsulinemia
impair
glucos
toler
reduc
glucos
dispos
glucos
clamp
puzzl
biochem
cellular
genet
underpin
linkag
hepat
insulin
resist
nash
identifi
yet
possibl
reflect
divers
metabol
inflammatori
fibrogen
cell
surviv
mechan
implic
pathogenesi
nash
key
hurdl
insulin
affect
process
differ
way
exampl
nash
hepatocyt
surviv
reduc
indic
resist
prosurviv
action
insulin
contrast
lipogenesi
increas
consist
lipogen
action
insulin
metabol
abnorm
obes
metabol
syndrom
character
insulin
resist
commonli
accept
risk
factor
nash
thu
reason
link
insulin
resist
nafldnash
hepat
insulin
resist
synonym
defect
abil
insulin
suppress
glycogenolysi
gluconeogenesi
thu
caus
elev
hepat
glucos
product
insulin
resist
hyperinsulinemia
favor
fat
accumul
liver
promot
de
novo
lipogenesi
least
partli
induc
express
lipogen
gene
nuclear
sterol
regulatori
elementbind
protein
master
regul
transcript
lipogen
enzym
insulin
resist
also
elev
fat
accumul
liver
increas
fatti
acid
mobil
adipos
tissu
redistribut
liver
decreas
mitochondri
debat
role
insulin
resist
pathogenesi
nafldnash
persist
unresolv
question
could
least
part
attribut
pauciti
anim
model
manifest
insulin
resist
replic
adequ
featur
human
diseas
histor
lack
anim
model
prevent
sustain
research
effort
area
dearth
anim
model
recapitul
featur
nash
among
commonli
employ
model
obob
obes
mice
inositolphosphatas
pten
null
mice
adiposetissu
transgen
mice
kka
mice
mice
null
mutat
hepat
leptindefici
obob
mice
extrem
resist
insulin
contrast
moder
insulin
resist
state
human
diseas
exhibit
alter
leptin
signal
contrast
permiss
effect
leptin
inflamm
fibrosi
lipogenesi
also
limit
use
liverspecif
pten
knockout
mice
owe
insulin
sensit
lean
well
degre
steatosi
typic
associ
human
nash
adipos
tissu
transgen
mous
display
nashlik
liver
histolog
exhibit
lipodystrophi
hypoleptinemia
togeth
sever
insulin
resist
fulli
replic
clinic
manifest
nash
diet
similarli
induc
nash
phenotyp
least
part
wide
use
induc
fibrosi
methionin
cholin
defici
mcd
diet
howev
human
nash
exhibit
methionin
cholin
defici
diet
caus
insulin
resist
diet
rich
highfat
cholesterol
cholat
fructos
also
commonli
use
truli
mimick
either
biochem
full
clinic
manifest
nash
genet
dietari
model
collect
fail
adequ
probe
role
insulin
resist
diseas
process
progress
nash
involv
hepat
lipid
accumul
contribut
proinflammatori
state
liver
lipotox
signal
activ
kupffer
cell
resid
macrophag
liver
releas
proinflammatori
molecul
chemokin
recruit
inflammatori
cell
contribut
product
fibrogen
mediat
activ
stellat
cell
caus
hepat
fibrosi
nash
progress
also
involv
hepatocellular
injuri
result
hepatocyt
apoptosi
oxid
stress
endoplasm
reticulum
er
stress
addit
grow
bodi
work
implic
extrahepat
cellular
event
progress
nash
among
releas
ffa
proinflammatori
adipokin
white
adipos
tissu
next
review
major
extrahepat
local
inflammatori
mechan
involv
nafld
progress
nash
hepat
mechan
involv
inflammatori
phenotyp
hepatocellular
injuri
nashviscer
obes
insulin
resist
contribut
develop
sever
metabol
type
diabet
nafld
cardiovascular
diseas
condit
system
insulin
resist
ffa
releas
white
adipos
tissu
distribut
organ
includ
liver
vascular
system
moreov
liver
equip
lipogen
enzym
induc
hyperinsulinemia
henc
increas
fat
accumul
liver
attribut
lipolysi
also
elev
hepat
novo
lipogenesi
particular
condit
chronic
hyperinsulinemia
ectop
fat
accumul
liver
alter
inflammatori
milieu
least
partli
caus
increas
local
express
proinflammatori
gene
could
exacerb
nafld
insulin
resist
liver
harbor
sever
immun
cell
lymphocyt
nk
cell
dendrit
cell
take
part
nash
inflammatori
process
profil
genet
chang
progress
obes
nash
identifi
liverspecif
genet
signatur
nash
patient
sever
gene
found
upregul
liver
patient
nash
comparison
patient
nafld
morbid
obes
includ
gene
encod
chemokin
receptor
involv
leukocyt
recruit
cd
notabl
cytokin
involv
steer
cell
activ
toward
phenotyp
contrast
chang
serum
viscer
adipos
tissu
immun
map
increas
level
level
independ
nash
also
detect
patient
simpl
nafld
similar
result
domin
cytokin
profil
also
report
liver
obes
children
nash
patholog
condit
obes
prolong
high
fat
intak
liver
boost
fatti
acid
compensatori
mechan
limit
fat
accumul
oxid
stress
result
uncheck
fatti
acid
oxid
lipid
occur
togeth
reduct
mitochondri
glutathion
gsh
oxid
may
lead
activ
inflammatori
pathway
indirectli
caus
insulin
resist
mitochondri
dysfunct
sequenc
event
liver
caus
suscept
injuri
cell
death
hepat
progress
liver
diseas
addit
oxid
stress
inflammatori
pathway
involv
activ
unfold
protein
respons
upr
er
stress
link
metabol
abnorm
obes
type
diabet
hepat
steatosi
moreov
signal
mediat
apoptosi
appear
regul
hepat
steatosi
insulin
resist
bolster
observ
delet
protect
steatohepat
dietinduc
rise
inflammatori
state
insulin
resist
liver
moreov
mice
hepatocytespecif
hematopoieticloss
exhibit
hepat
mice
specif
loss
hematopoiet
cell
manifest
mark
decreas
level
show
hematopoiet
cell
princip
regul
express
jnk
function
addit
hepatocyt
liver
contain
larg
number
resid
macrophag
known
kupffer
cell
constitut
hepat
nonparenchym
cell
cell
phagocyt
activ
produc
cytokin
well
chemokin
initi
inflamm
induc
cell
death
kupffer
cell
implic
liver
respons
infect
toxin
stressor
includ
fat
accumul
howev
role
hepat
steatosi
nafld
fulli
delin
gener
adipos
affect
immun
cellular
respons
liver
way
similar
white
adipos
tissu
see
rel
limit
increas
macrophag
recruit
moreov
popul
macrophag
nash
exhibit
bia
mice
support
strain
favor
disposit
diseas
patient
nafld
display
increas
intestin
permeabl
could
elev
circul
lipopolysaccharid
lp
activ
cell
type
liver
includ
kupffer
cell
produc
reactiv
oxygen
speci
ro
proinflammatori
cytokin
caus
liver
injuri
nash
induc
insulin
resist
ro
promot
lipid
peroxid
oxid
stress
furthermor
activ
kupffer
cell
produc
transform
growth
turn
contribut
activ
hepat
stellat
cell
main
cell
collagen
product
liver
mediat
extracellular
matrix
deposit
promot
fibrosi
point
role
macrophag
inflammatori
pathway
hepat
fibrosi
inde
patient
nafld
develop
igg
antibodi
lipid
peroxidationderiv
antigen
associ
advanc
fibrosi
thu
activ
kupffer
cell
contribut
numer
process
nash
progress
steatosi
apoptosi
inflamm
fibrosi
liver
also
home
nk
cell
well
natur
killer
nkt
cell
uniqu
subset
regulatori
lymphocyt
innat
immun
system
nk
cell
modul
hepat
tcell
respons
addit
directli
promot
death
hepatocyt
activ
stellat
cell
nkt
cell
implic
liver
injuri
primari
function
mediat
balanc
local
product
proinflammatori
antiinflammatori
cytokin
among
proinflammatoryantifibrogen
cytokin
releas
nkt
cell
among
antiinflammatoryprofibrogen
respons
nash
associ
rel
imbal
favor
proinflammatori
respons
nkt
cell
especi
abund
liver
patient
nafld
manifest
decreas
peripher
nkt
cell
number
owe
part
cell
death
kupffer
cellsderiv
proinflammatori
cytokin
obob
mice
pool
nkt
cell
decreas
correl
elev
hepat
product
cytokin
sever
steatosi
adopt
transfer
produc
regulatori
nkt
cell
amelior
steatosi
normal
glucos
homeostasi
decreas
level
proinflammatori
cytokin
mice
hand
studi
show
nkt
popul
increas
rather
decreas
nafld
progress
latestag
diseas
propos
potenti
role
nkt
advanc
patholog
fibrosi
role
adipos
tissuederiv
adipokin
nashclin
studi
shown
white
viscer
fat
key
mediat
liver
inflamm
fibrosi
independ
metabol
abnorm
nash
insulin
resist
hepat
steatosi
even
though
exact
role
adipokin
hepat
insulin
resist
nafld
remain
fulli
elucid
alter
adipokin
pattern
observ
patient
develop
insulin
resist
well
obes
patient
nafld
viscer
adipos
tissu
hormon
activ
produc
sever
adipokin
contribut
insulin
resist
alter
glucos
fat
metabol
liver
adipokin
undergo
similar
chang
obes
patient
insulin
resist
nafld
independ
nash
nonetheless
contribut
insulin
resist
state
associ
diseas
also
macrophag
recruit
liver
activ
resid
macrophag
fibrogen
activ
stellat
cell
constitut
critic
compon
nash
pathogenesi
addit
role
develop
insulin
resist
play
key
role
initi
nafld
well
progress
nash
rodent
human
develop
fibrosi
progress
nash
activ
kupffer
cell
becom
major
supplier
treatment
antibodi
reduc
activ
jnk
pathway
prevent
progress
nafld
nash
obob
mice
patient
steatohepat
exhibit
elev
plasma
well
tissueassoci
level
receptor
increas
shown
posit
correl
advanc
stage
diseas
includ
degre
hepat
fibrosi
role
pathogenesi
nafld
remain
unclear
sever
clinic
studi
show
hepatocyt
express
correl
posit
plasma
level
degre
inflamm
fibrosi
patient
nash
specif
level
directli
associ
elev
viscer
fat
independ
predict
degre
liver
inflamm
patient
nash
addit
macrophag
could
releas
b
cell
part
adapt
immun
respons
induc
differenti
hepat
stellat
cell
myofibroblast
mediat
hepat
fibrosi
respons
mice
independ
tcell
antibodi
stimul
howev
proinflammatori
effect
challeng
observ
also
play
antiinflammatori
role
instanc
studi
show
exert
protect
mechan
liver
fibrosi
promot
hepatocyt
regener
prolifer
prevent
oxid
stress
mitochondri
dysfunct
consist
block
signal
exacerb
hepatocyt
apoptosi
liver
injuri
fibrosi
mcd
feddbdb
diabet
mice
model
present
sever
nash
patholog
thu
studi
need
delin
role
cytokin
pathogenesi
nash
leptin
leptin
releas
white
adipos
tissu
level
increas
plasma
patient
nafld
suggest
nafld
associ
leptin
resist
addit
insulin
resist
role
leptin
regul
energi
expenditur
immun
system
function
well
document
see
moreov
leptin
shown
activ
hepat
stellat
cell
consist
increas
leptin
receptor
express
cell
absenc
hepat
fibrosi
leptindefici
obob
mice
import
note
serum
leptin
level
uniformli
associ
advanc
fibrosi
level
hepat
leptin
receptor
mrna
express
human
adiponectin
contrast
leptin
adiponectin
level
lower
patient
develop
steatosi
patient
nash
sever
liver
injuri
furthermor
adiponectin
plasma
level
invers
associ
plasma
level
contrast
nash
patient
cirrhot
liver
diseas
manifest
increas
adiponectin
level
regardless
adiponectin
shown
suppress
alcohol
well
nonalcohol
fatti
liver
diseas
liver
fibrosi
mice
suppress
er
stress
transgen
mice
overexpress
adipos
tissu
mous
model
nash
thu
like
adiponectin
benefici
effect
metabol
diseas
fibros
steatohepat
mice
structur
topolog
previous
call
biliari
glycoprotein
bgp
highli
conserv
broadli
distribut
member
cea
molecul
express
epitheli
cell
endotheli
lymphoid
myeloid
cell
type
membran
glycoprotein
singl
transmembran
domain
najjar
et
al
initi
show
gene
consist
exon
th
undergo
altern
splice
gener
either
long
aa
depend
speci
short
intracellular
tail
subsequ
mous
human
gene
found
undergo
similar
altern
splice
event
import
note
cytoplasm
tail
highli
conserv
among
speci
fulllength
protein
consist
membranedist
ig
variabl
domain
igv
like
amino
n
termin
domain
region
highli
conserv
among
cea
famili
member
follow
membraneproxim
ig
constant
domainrel
sequenc
ndomain
mediat
homophil
intercellular
adhes
simplic
review
refer
function
long
isoform
contain
two
tyrosin
phosphoryl
site
cytoplasm
tail
harbor
regulatori
mechan
function
pertain
insulin
resist
nash
pathogenesi
name
role
suppress
inflamm
steatosi
promot
insulin
action
liver
express
predominantli
lcisdim
cell
membran
immun
cell
also
engag
transhomophil
transheterophil
intercellular
bind
monom
express
low
rest
nk
cell
mice
human
upon
stimul
undergo
rapid
mobil
intracellular
compart
via
lipid
raft
becom
strongli
upregul
cell
surfac
class
cell
surfac
membran
act
coinhibitori
receptor
cell
receptor
tcr
complex
homophil
interact
especi
antigenpres
cell
express
b
cell
dentrit
cell
macrophag
result
inhibit
cytokin
product
mostli
cytotox
nk
cell
via
class
mhcindepend
inhibitori
mechan
bind
src
homolog
domain
phosphatas
human
mediat
associ
complex
calmodulin
enter
immun
synaps
mechanist
tcr
activ
stimul
phosphoryl
srckinas
lck
fyn
cytoplasm
tail
tyrosin
phosphoryl
immunoreceptor
tyrosinebas
inhibitori
motif
itim
ivxyxxl
v
stabil
monom
cell
surfac
mediat
associ
turn
dephosphoryl
srcand
sykkinas
particular
sykrel
kinas
major
regul
integr
tcr
signal
primari
spleen
b
cell
constitut
express
cell
may
act
either
costimulatori
coinhibitori
recent
evid
show
similar
neg
role
tcr
signal
cell
act
neg
coreceptor
b
cell
receptor
human
cell
express
dentrit
cell
function
cell
remain
determin
contrast
function
neutrophil
thoroughli
investig
highli
express
neutrophil
abund
leukocyt
neutrophil
mediat
inflamm
produc
chemokin
cytokin
reduc
product
lpsactiv
neutrophil
recruit
phosphatas
complex
form
phosphoryl
syk
downregul
activ
inhibit
inflammasom
activ
key
inhibitori
coreceptor
role
neutrophil
coupl
rel
higher
express
cell
monocyt
macrophag
consist
higher
demand
neg
regul
inflammasom
neutrophil
domin
murin
bone
marrow
nonetheless
reason
predict
appli
similar
antiinflammatori
effect
macrophag
monocyt
upon
releas
pancreat
insulin
reach
liver
via
portal
circul
undergo
rapid
clearanc
insulin
clear
first
pass
liver
process
involv
intracellular
uptak
insulin
via
receptor
clathrinco
pit
vesicl
acid
environ
endosom
insulin
dissoci
receptor
undergo
degrad
insulin
degrad
enzym
receptor
undergo
recycl
membran
note
insulin
clearanc
mainli
occur
liver
lower
extent
kidney
review
shown
undergo
phosphoryl
insulin
receptor
tyrosin
kinas
tyrosin
number
appli
rat
protein
phosphoryl
requir
intact
serin
residu
cytoplasm
tail
upon
phosphoryl
take
part
insulinreceptor
complex
increas
rate
receptormedi
insulin
endocytosi
degrad
hepatocyt
concomit
increas
entri
cell
promot
associ
fatti
acid
synthas
fa
critic
enzym
de
novo
lipogenesi
liver
caus
detach
insulinreceptor
complex
promot
destabil
subsequ
insulin
dissoci
receptor
follow
degrad
bind
fa
mediat
acut
inhibitori
effect
fa
enzymat
activ
insulin
acut
neg
effect
insulin
fa
activ
mediat
pulsatil
insulin
outflow
portal
vein
pancreat
moreov
consist
physiolog
low
level
fa
activ
liver
thu
propos
phosphoryl
acut
rise
insulin
puls
bestow
liver
protect
mechan
normal
higher
level
insulin
system
circul
condit
obes
hyperinsulinemia
insulin
secret
induc
pulsatil
reduc
phosphoryl
lost
subsequ
neg
acut
effect
insulin
give
way
posit
chronic
effect
transcript
lipogen
enzym
induc
novo
lipogenesi
liver
mechan
mediat
acut
coinhibitori
effect
insulin
signal
lipogenesi
promot
unifi
acut
downregulatori
effect
insulin
gluconeogenesi
lipogenesi
regulatori
effect
insulin
intern
degrad
bolster
observ
mice
liverspecif
dominantneg
transgen
inactiv
harbor
nonphosphoryl
serin
alanin
mutat
mice
global
null
mutat
gene
develop
impair
insulin
clearanc
caus
hyperinsulinemia
chronic
hyperinsulinemia
caus
system
insulin
resist
shown
hyperinsulinemiceuglycem
clamp
analys
also
induc
transcript
lipogen
enzym
liver
includ
fa
result
increas
hepat
lipid
product
output
follow
substrat
redistribut
white
adipos
tissu
eventu
viscer
obes
histolog
examin
liver
section
reveal
mutant
develop
microsteatosi
regular
chow
diet
also
develop
proinflammatori
state
mark
elev
tissueassoci
macrophag
level
liver
adipos
tissu
aorta
popul
hepat
cell
basal
higher
wild
type
mice
function
inactiv
hepatocyt
similar
increas
pool
mice
condit
delet
cell
suggest
rise
due
least
part
loss
cell
rather
hepatocyt
elev
hepat
mrna
content
without
chang
level
demonstr
phenotyp
null
mice
detect
obes
children
rise
leptin
level
could
contribut
inflammatori
phenotyp
moreov
import
note
null
mous
exhibit
spontan
system
neutrophilia
high
hepat
popul
result
neutrophil
progenitor
cell
hyperprolifer
neutrophilia
could
also
contribut
strongli
develop
proinflammatori
state
null
mice
remark
mutant
also
develop
spontan
pericellular
fibrosi
consist
insulin
resist
independ
predictor
fibrosi
nash
find
reveal
uniqu
anim
model
other
fail
develop
fibrosi
regular
diet
basal
fibrosi
null
mice
could
attribut
elev
hepat
content
profibrogen
factor
despit
rise
togeth
could
reduc
collagen
synthesi
limit
profibrogen
effect
collect
demonstr
regular
chow
diet
mutant
mice
spontan
develop
state
mimick
fibros
steatohepat
human
addit
insulin
resist
viscer
obes
sustain
high
fat
hf
feed
trigger
inflamm
caus
sever
patholog
metabol
alter
mutant
similar
detect
patient
progress
nash
lipid
accumul
hepatocyt
despit
increas
fatti
acid
histolog
highfat
feed
caus
diffus
macrosteatosi
liver
also
reduc
niemannpick
c
protein
level
consequ
lower
gsh
presum
mitochondria
could
theoret
enhanc
sensit
cytotox
effect
consist
hf
diet
elev
depend
activ
oxid
stress
inflammatori
pathway
high
fat
feed
caus
progress
fibrosi
mutant
mice
nashcharacterist
chickenwir
fibrogen
deposit
pattern
occur
parallel
induct
leptin
level
without
alter
tissu
content
antifibrogen
profibrogen
modul
respect
thu
plausibl
exagger
fibrosi
develop
mice
respons
hf
feed
stem
increas
apoptosi
turn
lead
fibrosi
inflamm
exacerb
profibrogen
effect
elev
leptin
could
contribut
progress
fibrosi
respons
hf
feed
import
note
wild
type
mice
hf
feed
elev
hepat
without
caus
nashlik
fibrogen
chang
possibl
owe
failur
hf
diet
alter
express
liver
wild
type
mice
summari
liverspecif
inactiv
global
null
mutat
caus
system
insulin
resist
addit
clinic
biochem
featur
fibros
steatohepat
macrosteatosi
inflamm
apoptosi
necrosi
chickenwir
fibrosi
progress
nash
respons
inflammatori
cue
elicit
sustain
high
fat
intak
moreov
global
delet
gener
proinflammatori
state
typic
detect
nash
patient
includ
inflammatori
phenotyp
neutrophilia
thu
mutant
mice
indisput
reliabl
replic
human
diseas
provid
valuabl
tool
understand
molecular
underpin
nash
import
find
highlight
recent
report
demonstr
mark
decreas
level
liver
obes
subject
fatti
liver
diseas
independ
diabet
phenotyp
mice
consist
pleotrop
effect
facet
diseas
promot
insulin
clearanc
maintain
insulin
sensit
prevent
viscer
obes
mediat
coinhibitori
physiolog
acut
downregulatori
effect
insulin
de
novo
synthesi
fatti
acid
liver
exert
coinhibitori
effect
immun
cell
lymphoid
well
myeloid
lineag
henc
loss
constitut
miss
link
insulin
resist
chang
inflammatori
metabol
process
involv
pathogenesi
viscer
obes
nash
uniqu
identifi
loss
unifi
mechan
link
immunolog
metabol
abnorm
nash
promot
import
therapeut
target
devast
diseas
